AB2 Bio Ltd.
Industry / private company
Location:
Lausanne,
Switzerland (CH)
ISNI: -
ROR: https://ror.org/042xj9h52
Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's disease (2018)
Gabay C, Fautrel B, Rech J, Spertini F, Feist E, Koetter I, Hachulla E, et al.
Journal article
OPEN-LABEL, MULTICENTER, DOSE-ESCALATING PHASE II CLINICAL TRIAL ON THE SAFETY AND EFFICACY OF TADEKINIG ALPHA IN ADULT ONSET STILL'S DISEASE (2017)
Gabay C, Fautrel B, Rech J, Spertini F, Feist E, Koetter I, Hachulla E, et al.
Conference contribution